![Kay Holcombe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kay Holcombe
Président chez
The National Organization for Rare Disorders, Inc.
Profil
Kay Holcombe is currently the Chairman at The National Organization for Rare Disorders, Inc. She is also currently serving as the Director at Critical Path Institute and Reagan-udall Foundation.
Previously, she held the position of Senior Vice President-Science Policy at Biotechnology Innovation Organization.
Postes actifs de Kay Holcombe
| Sociétés | Poste | Début |
|---|---|---|
The National Organization for Rare Disorders, Inc.
 The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services Provides medical funding and healthcare services | Président | - |
Critical Path Institute
 Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Provides medical drug and product development review process | Directeur/Membre du Conseil | - |
Reagan-udall Foundation
 Reagan-udall Foundation The Reagan-Udall Foundation is a non-profit company dedicated to advancing regulatory science and innovation. The company is based in Washington, DC. The foundation collaborates with various stakeholders to enhance public health and safety through research and development initiatives. Susan C. Winckler has been the CEO of the company since 2020. | Directeur/Membre du Conseil | - |
Anciens postes connus de Kay Holcombe
| Sociétés | Poste | Fin |
|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
48
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
The National Organization for Rare Disorders, Inc.
The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services Provides medical funding and healthcare services | Health Services |
Critical Path Institute
Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Provides medical drug and product development review process | Commercial Services |
Reagan-udall Foundation
Reagan-udall Foundation The Reagan-Udall Foundation is a non-profit company dedicated to advancing regulatory science and innovation. The company is based in Washington, DC. The foundation collaborates with various stakeholders to enhance public health and safety through research and development initiatives. Susan C. Winckler has been the CEO of the company since 2020. |
